Ken Lim, M.D., Ph.D., M.Phil., F.A.S.N., F.A.H.A., is an American Physician-Scientist, Nephrologist and Entrepreneur. He holds appointments as Tenure-Track Assistant Professor of Medicine and Adjunct Assistant Professor of Anatomy, Cell Biology & Physiology at Indiana University School of Medicine (IUSM), and Attending Physician at IU Health. Prior to joining the faculty at IUSM in 2020, he spent over 10 years at Harvard Medical School and affiliated major teaching hospitals, later becoming Attending Physician at The Massachusetts General Hospital and a faculty member at Harvard Medical School. In 2022, he was named by the Indianapolis Business Journal (IBJ) to the Forty Under 40 Award for his contributions to medicine and work in healthcare-related issues of humanitarian crises.
The mission of his work is to create potential solutions to challenging issues of humanitarian need in healthcare and human suffering through innovative research, entrepreneurship and the delivery of medical care beyond borders. He is a clinical trialist and translational scientist, and leads a research group at IUSM that focuses on the development and delivery of definitive trials in patients with kidney failure and cardiovascular complications, and the development of advanced therapeutics. He founded the first Cardiopulmonary Exercise Testing (CPET) laboratory dedicated to the study of patients with kidney disease in the United States. He continues to be engaged in starting new companies at the forefront of innovation to bring sustainable impact, and translational strategies for taking biological discoveries into early phase exploratory trials.
Dr. Lim has deployed to regions around the world to provide leading medical care and strategic principles to help meet critical needs of victims of humanitarian crises, such as war, poverty and natural disasters. He has served as strategic advisor or consultant to leaders from diverse sectors, he has held offices of leadership on numerous boards and has appeared on various television and media programs. He is a graduate of The University of Cambridge (Christ’s College) and The University of Warwick in England.